Morgan Stanley reissued their overweight rating on shares of AXA (OTCMKTS:AXAHY) in a research note issued to investors on Wednesday, The Fly reports.
Other analysts have also recently issued reports about the company. Societe Generale reaffirmed a buy rating on shares of AXA in a research note on Tuesday, December 15th. UBS Group reaffirmed a neutral rating on shares of AXA in a research report on Monday, November 16th. Barclays reaffirmed an overweight rating on shares of AXA in a research report on Tuesday, November 24th. Zacks Investment Research raised AXA from a sell rating to a hold rating in a report on Wednesday, December 16th. Finally, Nord/LB upgraded AXA from a hold rating to a buy rating in a research note on Thursday, November 5th. Two investment analysts have rated the stock with a sell rating, two have given a hold rating and eight have issued a buy rating to the company’s stock. The company has a consensus rating of Buy and an average target price of $23.00.
AXA stock opened at $24.59 on Wednesday. The stock has a market capitalization of $59.39 billion, a price-to-earnings ratio of 8.20, a P/E/G ratio of 2.27 and a beta of 1.45. AXA has a 12-month low of $12.72 and a 12-month high of $27.72. The stock has a 50-day simple moving average of $24.08 and a 200 day simple moving average of $20.96.
AXA SA, through its subsidiaries, provides insurance and asset management services worldwide. It operates in seven segments: France, Europe, Asia, AXA XL, the United States, International, and Transversal & Central Holdings. The company offers a range of insurance products, including life and savings, property and casualty, and health.
Recommended Story: What is a stock split?
Receive News & Ratings for AXA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AXA and related companies with MarketBeat.com's FREE daily email newsletter.